摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(3aR,5aR,6R,7R,8aR,8bS)-1-benzyl-5a-methyl-1,3,3a,5a,6,7,8a,8b-octahydro-6,7-isopropylideneoxy-4H-furo[2',3':3,2]pyrano[4,5-c]isoxazole | 170639-35-7

中文名称
——
中文别名
——
英文名称
(3aR,5aR,6R,7R,8aR,8bS)-1-benzyl-5a-methyl-1,3,3a,5a,6,7,8a,8b-octahydro-6,7-isopropylideneoxy-4H-furo[2',3':3,2]pyrano[4,5-c]isoxazole
英文别名
(1R,2S,6R,9R,10R,14R)-3-benzyl-9,12,12-trimethyl-4,8,11,13,15-pentaoxa-3-azatetracyclo[7.6.0.02,6.010,14]pentadecane
(3aR,5aR,6R,7R,8aR,8bS)-1-benzyl-5a-methyl-1,3,3a,5a,6,7,8a,8b-octahydro-6,7-isopropylideneoxy-4H-furo[2',3':3,2]pyrano[4,5-c]isoxazole化学式
CAS
170639-35-7
化学式
C19H25NO5
mdl
——
分子量
347.411
InChiKey
CJQSROISVAOEJK-PDDMAZILSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    25
  • 可旋转键数:
    2
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.68
  • 拓扑面积:
    49.4
  • 氢给体数:
    0
  • 氢受体数:
    6

反应信息

  • 作为反应物:
    描述:
    参考文献:
    名称:
    3- O-烯丙基碳水酮硝酮环加成(3-OACNC)合成手性氧杂环丁烷和吡喃
    摘要:
    3- ø从3- -Allylcarbohydrate硝酮环加成(3- OACNC)布置吡喃和氧杂环庚烷衍生物ø -烯丙基己糖ñ -苄基硝酮和3- ö烯丙基呋喃-5-醛ñ -苄基/甲基硝酮。发现3-OACNC的区域选择性取决于以下因素(a)硝酮的结构性质(b)碳水化合物主链在3-C处的取代和立体化学(c)在O末端的取代-烯丙基部分。从特定组的己糖硝酮和相应的呋喃糖苷硝酮获得的氧杂环丁烷或吡喃通过降解转化为对映体环状醚。在3- O-烯丙基碳水合物衍生的肟的分子内肟环烯烃加成反应(IOOC )中形成环氧丙烷和吡喃的混合物。
    DOI:
    10.1016/s0040-4020(03)00634-3
  • 作为产物:
    描述:
    3-O-allyl-1,2-O-isopropylidene-3-C-methyl-α-D-allofuranose 在 sodium periodate 作用下, 以 氯仿 为溶剂, 反应 2.0h, 生成 (3aR,5aR,6R,7R,8aR,8bS)-1-benzyl-5a-methyl-1,3,3a,5a,6,7,8a,8b-octahydro-6,7-isopropylideneoxy-4H-furo[2',3':3,2]pyrano[4,5-c]isoxazole
    参考文献:
    名称:
    3- O-烯丙基碳水酮硝酮环加成(3-OACNC)合成手性氧杂环丁烷和吡喃
    摘要:
    3- ø从3- -Allylcarbohydrate硝酮环加成(3- OACNC)布置吡喃和氧杂环庚烷衍生物ø -烯丙基己糖ñ -苄基硝酮和3- ö烯丙基呋喃-5-醛ñ -苄基/甲基硝酮。发现3-OACNC的区域选择性取决于以下因素(a)硝酮的结构性质(b)碳水化合物主链在3-C处的取代和立体化学(c)在O末端的取代-烯丙基部分。从特定组的己糖硝酮和相应的呋喃糖苷硝酮获得的氧杂环丁烷或吡喃通过降解转化为对映体环状醚。在3- O-烯丙基碳水合物衍生的肟的分子内肟环烯烃加成反应(IOOC )中形成环氧丙烷和吡喃的混合物。
    DOI:
    10.1016/s0040-4020(03)00634-3
点击查看最新优质反应信息

文献信息

  • Synthesis of enantiomeric pyrans from a 3--allylallose derivative by the application of intramolecular nitrone cycloaddition
    作者:Ashoke Bhattacharjee、Anup Bhattacharjya、Amarendra Patra
    DOI:10.1016/0040-4039(95)00832-w
    日期:1995.6
    The intramolecular nitrone cycloaddition of three sets of 3-O-allylpyranose and the corresponding homochiral 3-O-allylfuranose-5-aldehyde derivatives was studied; one set derived from D-allose gave rise to only pyran derivatives which were converted to enantiomeric pyranoisoxazolidines via minor degradations.
  • Synthesis of chiral oxepanes and pyrans by 3-O-allylcarbohydrate nitrone cycloaddition (3-OACNC)
    作者:Ashoke Bhattacharjee、Seema Datta、Partha Chattopadhyay、Nanda Ghoshal、Asish P Kundu、Arani Pal、Ranjan Mukhopadhyay、Sandip Chowdhury、Anup Bhattacharjya、Amarendra Patra
    DOI:10.1016/s0040-4020(03)00634-3
    日期:2003.6
    3-O-Allylcarbohydrate nitrone cycloaddition (3-OACNC) furnished pyran and oxepane derivatives from 3-O-allyl hexose N-benzyl nitrones and 3-O-allyl furanoside-5-aldehyde N-benzyl/methyl nitrones. The regioselectivity of 3-OACNC was found to depend on the following factors (a) the structural nature of the nitrone (b) substitution and stereochemistry at 3-C of the carbohydrate backbone (c) substitution
    3- ø从3- -Allylcarbohydrate硝酮环加成(3- OACNC)布置吡喃和氧杂环庚烷衍生物ø -烯丙基己糖ñ -苄基硝酮和3- ö烯丙基呋喃-5-醛ñ -苄基/甲基硝酮。发现3-OACNC的区域选择性取决于以下因素(a)硝酮的结构性质(b)碳水化合物主链在3-C处的取代和立体化学(c)在O末端的取代-烯丙基部分。从特定组的己糖硝酮和相应的呋喃糖苷硝酮获得的氧杂环丁烷或吡喃通过降解转化为对映体环状醚。在3- O-烯丙基碳水合物衍生的肟的分子内肟环烯烃加成反应(IOOC )中形成环氧丙烷和吡喃的混合物。
查看更多

同类化合物

马桑宁内酯 苦毒浆果[木防已属] 苦亭 艾瑞布林中间体 艾瑞布林 甲磺酸艾日布林 木防己苦毒宁 全内酯 二氢苦毒宁 6-甲基-4-氧代-4H-呋喃并[3,2-c]吡喃-3-甲酰氯 6-(4-羟基苯基)-2,3,3-三甲基-2H-呋喃并[5,4-b]吡喃-4-酮 4H-呋喃并[2,3-c]吡喃基莫匹罗星钠 3-甲基2H-呋喃并[2,3-c]吡喃-2-酮 3,5-二甲基2H-呋喃并[2,3-c]吡喃-2-酮 2H-呋喃并[2,3-c]吡喃-2-酮 2-[(1E,3E)-己-1,3-二烯基]-2,6-二甲基-5,6-二氢呋喃并[5,4-b]吡喃-3,4-二酮 (3aS,5S,6R,9E,14R,15R,15aR)-2,3,3a,4,5,6,7,8,11,12,13,14,15,15alpha-十四氢-6,10,14-三甲基-3-亚甲基-2-氧代-5,15-环氧环十四烷并[b]呋喃-6-醇乙酸酯 (3aR,4S,7aR)-4-羟基-3,3a,4,7a-四氢呋喃并[5,4-b]吡喃-2-酮 5-hydroxymethyl-3-methyl-2H-furo[2,3-c]pyran-2-one 5-fluoromethyl-2H-furo[2,3-c]pyran-2-one 5-chloromethyl-2H-furo[2,3-c]pyran-2-one 10,11-Anhydro-5-deoxy-1,2-O-isopropylidene-9-O-(methoxymethyl)-β-L-xylo-L-ido-7-undeculofuranose-(1,4)-pyranose-(7,3) 3,7-dimethyl-2H-furo[2,3-c]pyran-2-one 4R-(3αβ,3aβ,4β,5α,6β,7aβ)hexahydro-2,2-dimethyl-4,5-bis(phenylmethoxy)-6-[(phenylmethoxy)methyl]4H-furo[2,3-b]pyran-3-ol 10,10-dimethyl-5-(methylsulfanyl)-10,11-dihydro-8H-pyrano[4',3':4,5]furo[3,2-e]tetrazolo[1,5-c]pyrimidine (R)-3-((2R,3R,5aR,7R,9aS)-3-hydroxyhexahydro-2H-2,5a-methanopyrano[3,2-e][1,4]dioxepin-7-yl)-2-methylpropanenitrile 13-methyl-8,10,12-trioxapentacyclo[5.5.2.02,6.O3,11.05,9]-13-tetradecene 2,3,4,4a,7,8-Hexahydro-6H-2-(acetoxymethyl)-3,4-diacetoxy-1,9-dioxacyclohexainden-5-one 2,3,4,4a,7,8-Hexahydro-6H-2-methoxy-1,9-dioxacyclohexainden-5-one (-)-3a-methyl-3a,4-dihydro-1H,3H-furo[3,4-c]pyran-6,6,7-tricarboxylic acid 6,6-diethyl ester 7-methyl ester (+)-8-epi-altholactone 4-(perfluorophenyl)-3-phenylhexahydro-1H-furo[3,4-c]pyran [(2R,11S,12R,14R,15R,17R,19S)-19-tert-butyldiphenylsiloxymethyl-15-methyl-13,18-dioxadispiro(2H-3,6-dihydropyran-6,5'-oxolane-2',3''-bicyclo[4.3.0]nonane)-2-yl]phenylmethoxymethane (3aS,5S,9bS)-5-methyl-3,3a-dihydro-5H-furo[3,2-c]isochromene-2,6,9-(9bH)-trione (3aR,5R,7aR)-5-(2-hydroxypropan-2-yl)-7a-methylhexahydro-2H-furo[3,2-b]pyran-2-one 2,2,3b-trimethyl-7-vinyl-3a,5,7a,8a-tetrahydro-3bH-1,3,4,8-tetracyclopenta[a]indene ethyl 4-oxo-3-phenyl-3,3a,4,6-tetrahydro-1H-furo[3,4-c]pyran-3a-carboxylate methyl (2R,2aR,4aS,7aS,7bS)-2-methoxy-6-methyl-4-oxo-5-pentyl-2a,4,4a,7b-tetrahydro-2H-1,3,7-trioxacyclopenta[cd]indene-7a-carboxylate 4-nonyl-3-phenylhexahydro-1H-furo[3,4-c]pyran 3'-(4-methoxyphenyl)-7a'-methyl-4'H,6'H-spiro[cyclohexane-1,5'-furo[2,3-b]pyran]-2'(7a'H)-one 3',7a'-dimethyl-4'H,6'H-spiro[cyclohexane-1,5'-furo[2,3-b]pyran]-2'(7a'H)-one 2-(methylsulfanyl)-5,6-dihydro-4H-furo[2,3-b]pyran 1,1-(3-dimethylamino-3-phenylpentamethylen)-3,4-dihydro-1H-2,9-dioxafluoren 7-cyclopropyl-4,5,7,7a-tetrahydro-furo[2,3-c]pyran-2-one 7-cyclopropyl-3-phenyl-4,5,7,7a-tetrahydro-furo[2,3-c]pyran-2-one 7-cyclopropyl-3-phenyl-4,5,7,7a-tetrahydro-furo[2,3-c]pyran-2-one (4'R)-6-O-(4-cyanophenyl)-1,2,3,4-tetradeoxy-4'-(2,2,3,3,4,4,5,5,6,6,7,7,8,8,9,9,9-heptadecafluorononyl)-2',3',4',5'-tetrahydro-α-D-erythro-hexopyranoso[1,2-b]furan 2,2,3,6-tetramethyl-2,3-dihydro-4H-furo[2,3-b]pyran-4-one (1aR,4aS,5R)-7-carboethoxy-5-methylethyl-tetrahydrofurano[2,3-b]3,4-dihydro-2H-pyran (3aS,4S,7aR)-ethyl 4-methyl-3,3a,4,7a-tetrahydro-2H-furo[2,3-b]pyran-6-carboxylate